No image

ARCHITECT

Lithium

Details

Device typeLithium therapeutic drug monitoring IVD, kit, spectrophotometry: A collection of reagents and other associated materials intended to be used for the quantitative measurement and therapeutic monitoring of the central nervous system drug lithium in a clinical specimen, using a spectrophotometry method.

FDA categoryAssay, porphyrin, spectrophotometry, lithium

Device ID00380740017712

Catalog number08L2530

AvailabilityPrescription

MRI safetyLabeling does not contain MRI Safety Information

Contact

Phone+1(877)422-2688

Emailxx@xx.xx

Related products

Product	Model	Company	Device type
DiazymeDiazyme Laboratories, Inc.Lithium therapeutic drug monitoring IVD, reagent	DZ116B-KH1	Diazyme Laboratories, Inc.	Lithium therapeutic drug monitoring IVD, reagent
VITROSOrtho-Clinical Diagnostics, Inc.Lithium therapeutic drug monitoring IVD, reagent	1632660	Ortho-Clinical Diagnostics, Inc.	Lithium therapeutic drug monitoring IVD, reagent
VITROSOrtho-Clinical Diagnostics, Inc.Lithium therapeutic drug monitoring IVD, reagent	8318925	Ortho-Clinical Diagnostics, Inc.	Lithium therapeutic drug monitoring IVD, reagent
ADVIA Chemistry Lithium_2 (LITH_2) reagentsSiemens Healthcare Diagnostics Inc.Lithium therapeutic drug monitoring IVD, kit, atomic spectroscopy	11532400	Siemens Healthcare Diagnostics Inc.	Lithium therapeutic drug monitoring IVD, kit, atomic spectroscopy